TP53 and cancer: The results demonstrate that the 26 potential targets are mainly involved in the following signaling pathways: age/rage signaling, cancer, human cytomegalovirus infection, interaction between cytokines and cytokine receptors, transcriptional imbalance in cancer, and p53 signaling.